 based on the company's recent earnings call, it is recommended to take an 'overweight' investment stance on the company. The company has shown steady organic sales growth in developing and emerging markets, particularly in Eastern Europe and China, as well as strong sales trends in North America. The company has also demonstrated a focus on financial discipline and cost savings, with excellent results on metrics such as margins, cash flow, and return on invested capital. In addition, the company has an optimistic outlook for 2017, with a target organic sales growth of approximately 2% and a focus on innovation and marketing initiatives to drive long-term success. The company is also committed to shareholder-friendly capital allocation, with plans to allocate between $2.2 billion and $2.4 billion to dividends and share repurchases in 2017. Overall, the company's solid performance and positive outlook make it an attractive investment opportunity.